Comparison
Why is Emergent BioSolutions, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -16.76% of over the last 5 years
2
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD 169 MM
- NET PROFIT(HY) Higher at USD 53.95 MM
- ROCE(HY) Highest at 30.24%
3
With ROE of -15.10%, it has a risky valuation with a 0.67 Price to Book Value
- Over the past year, while the stock has generated a return of 36.76%, its profits have fallen by -344%
4
Market Beating Performance
- The stock has generated a return of 36.76% in the last 1 year, much higher than market (S&P 500) returns of 14.11%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Emergent BioSolutions, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Emergent BioSolutions, Inc.
26.78%
0.89
93.93%
S&P 500
25.41%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
-13.74%
EBIT Growth (5y)
-24.11%
EBIT to Interest (avg)
4.18
Debt to EBITDA (avg)
4.15
Net Debt to Equity (avg)
0.93
Sales to Capital Employed (avg)
0.77
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
97.28%
ROCE (avg)
9.11%
ROE (avg)
7.50%
Valuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.80
EV to EBIT
7.19
EV to EBITDA
3.80
EV to Capital Employed
0.88
EV to Sales
1.06
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
12.31%
ROE (Latest)
14.43%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 148 MM
-25What is not working for the Company
PRE-TAX PROFIT(Q)
At USD 5 MM has Fallen at -81.01%
NET PROFIT(Q)
At USD 2.54 MM has Fallen at -86.54%
NET SALES(Q)
At USD 156.1 MM has Fallen at -15.95%
RAW MATERIAL COST(Y)
Grown by 17.73% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.17 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.16 times
Here's what is working for Emergent BioSolutions, Inc.
Operating Cash Flow
Highest at USD 148 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Emergent BioSolutions, Inc.
Pre-Tax Profit
At USD 5 MM has Fallen at -81.01%
over average net sales of the previous four periods of USD 26.32 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 2.54 MM has Fallen at -86.54%
over average net sales of the previous four periods of USD 18.85 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
At USD 156.1 MM has Fallen at -15.95%
over average net sales of the previous four periods of USD 185.72 MMMOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Inventory Turnover Ratio
Lowest at 1.17 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 4.16 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 17.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






